メディカルツーリズムの世界市場：2025年～2033年

メディカルツーリズムの世界市場は2024年に470億9,000万米ドルに達し、2033年には2,303億5,000万米ドルに達すると予測され、予測期間2025年のCAGRは19.4%で成長すると予測されています。

医療処置の低コスト化に対する意識の高まりは、メディカルツーリズム市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予想されます。メディカルツーリズムの主な動機は、患者がより良い患者の転帰を持つ他の国で治療を受けることによって達成できる大幅なコスト削減です。これはさらに、患者にとってより良い、より手頃な価格の治療のために多くを開始しました。

例えば、2022年8月、連邦保健省は、首相が発表した新しいポータルサイト「heal in India and heal by India」という新しい取り組みを開始しました。この新しいポータルは、メディカルツーリズムに弾みをつけることを目的としています。アユシュマン・バラット・デジタル・ミッションの下で開発されたこのポータルには、医療専門家や病院サービスのリポジトリがあり、インドで手頃な費用で医療支援を求める海外の患者を支援します。

医療処置の低コストに関する意識の高まりは、メディカルツーリズム市場の需要を加速させ、様々な処置のための医療ツーリストの数を増加させます。例えば、Lively, Inc.によると、冠動脈バイパス術の平均費用はインドで約1万米ドル、メキシコで約4万米ドル（目的地までの往復や退院後の国内での回復費用は含まず）、アメリカでは平均12万3,000ドルです。

DentaVacationによると、ハンガリーでは、歯科医の価格は、英国や他の西欧諸国よりも40～70％安くなっています。ハンガリーでは4本のインプラントのような処置が1本あたり5,200ドルかかるのに対し、英国では同じ処置に15,000ドルかかります。ラミネートベニアはハンガリーでは405ドルですが、英国ではなんと1,100ドルもします。

さらに、世界ヘルスケア認定によると、メキシコは70.05点で、メディカルツーリズム業界で3位にランクされました。メキシコは、質の高い医療施設と手頃な医療費で、メディカルツーリズム産業が成長しています。美容整形とがん治療の先進国保健福祉部（MOHW、チョ・ギュホン長官）は、2023年に韓国を訪れる外国人患者は60万6,000人で、2022年の24万8,000人から2.4倍の伸び（144.2％）を達成すると発表しました。このような低コストの処置に対する認識が、市場の需要を押し上げています。

メディカルツーリズムは急成長していますが、その拡大を妨げる課題もあります。主な懸念事項の1つは、医療渡航は時間のかかるプロセスであり、追加費用が発生する可能性があることです。このような要因は、潜在的な患者が海外での治療を選択することを躊躇させる可能性があります。治療のための海外渡航は、単に航空券を予約するだけではありません。通常、ビザの取得、医療提供者の調査、診察の日程調整、適切なアフターケアの確保など、長い計画プロセスが必要となります。時間が限られている患者や、緊急の治療が必要な患者にとって、これは大きな障壁となる可能性があります。

当レポートでは、世界のメディカルツーリズム市場について調査し、市場の概要とともに、タイプ別、治療別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第4章 戦略的洞察と業界の展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー
• メディカルツーリズムの未来

第5章 メディカルツーリズム市場、タイプ別

• 国際的メディカルツーリズム
• 国内メディカルツーリズム

第6章 メディカルツーリズム市場、治療別

• 治療
  • 歯科治療
  • 臓器移植
  • 心臓手術
  • 整形外科
  • がん手術
  • 不妊治療
  • 美容整形
  • その他
• 健康と若返り
• 伝統的な医療制度による治療

第7章 メディカルツーリズム市場、地域別市場分析と成長機会

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 中東・アフリカ

第8章 競合情勢と市場ポジショニング

第9章 企業プロファイル

• Raffles Medical Group
• Medobal
• Bookimed
• RealSelf, Inc.
• KPJ Healthcare Berhad
• Japan Dream Tour Co., Ltd.
• JTB Corp.
• SilaMed eK
• Medibliss Tours Limited
• American Medical Care

第10章 仮定と調査手法

第11章 付録

The global medical tourism market reached US$ 47.09 billion in 2024 and is expected to reach US$ 230.35 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.

Medical tourism refers to traveling to another country or region to seek medical treatment, often because it offers more affordable, higher-quality or specialized care than what is available in the traveler's home country. It encompasses various healthcare services, including elective procedures, dental, cosmetic surgeries, fertility treatments and more complex surgeries or medical interventions. Overall, medical tourism is a growing industry fueled by the desire for affordable, high-quality healthcare and the convenience of combining treatment with travel. However, patients must conduct thorough research regarding destination countries, healthcare providers and any associated risks before pursuing medical tourism.

The medical tourism market has seen rapid growth over the past few decades, driven by a combination of factors including rising healthcare costs in developed countries, advancements in medical technology, globalization, and the increasing affordability of travel. For instance, around 14 million people travel abroad each year to receive medical treatment, according to the Medical Tourism Association, with patients from developed nations such as the UK and the US typically traveling to less-developed countries to access health services at a significantly lower cost than they could at home.

Market Dynamics: Drivers & Restraints

Rising awareness about the low cost of medical procedures

The rising awareness about the low cost of medical procedures is significantly driving the growth of the medical tourism market and is expected to drive the market over the forecast period. The primary motivation for medical tourism is the substantial cost savings that patients can achieve by seeking medical treatment in other countries with better patient outcomes. This further initiated more for better and more affordable treatments for the patients.

For instance, in August 2022, the Union Health Ministry launched a new initiative, heal in India and heal by India, a new portal announced by the prime minister. The new portal aims to give impetus to medical tourism. Developed under the Ayushman Bharat Digital Mission, the portal will have a repository of healthcare professionals and hospital services to help overseas patients seeking medical help in India at an affordable cost.

Rising awareness about the low cost of medical procedures accelerates the medical tourism market demand, which increases the number of medical tourists for various procedures. For instance, according to Lively, Inc., a coronary bypass averages around $10,000 in India and $40,000 in Mexico (not including travel to and from the destination, or in-country recovery after release from the hospital) and $123,000 the average procedure costs in America.

According to DentaVacation, in Hungary, dentist prices are 40-70% less than in the UK and other Western European countries. Procedures like all 4 dental implants in Hungary cost $5,200 per arch, while the same costs $15,000 in the UK. We can get porcelain veneers in Hungary at $405, whereas in the UK, they'll cost a whopping $1,100.

Additionally, according to the Global Healthcare Accreditation, Mexico ranked third in the medical tourism industry, with a score of 70.05. Mexico has a growing medical tourism industry, with high-quality medical facilities and affordable medical costs. A leader in cosmetic surgery and cancer treatment. The Ministry of Health and Welfare (MOHW, Minister Cho KyooHong) announced that 606,000 foreign patients visited Korea in 2023, achieving a 2.4 times growth (144.2%) from 248,000 in 2022. These low cost procedures awareness boosts the market demand.

Medical traveling is a time-consuming process and is associated with some additional costs

Although medical tourism has been growing rapidly, it does come with certain challenges that can hamper its expansion, one of the primary concerns being that medical traveling is a time-consuming process and can incur additional costs. These factors can deter potential patients from opting for treatment abroad. Traveling abroad for medical treatment involves more than just booking a flight. It typically requires a lengthy planning process that includes obtaining visas, researching medical providers, scheduling consultations and ensuring appropriate aftercare. This can be a significant barrier for patients with limited time or those needing urgent care.

While the medical procedure itself may be much more affordable abroad, additional travel-related costs can accumulate. These include airfares, accommodation, transport and often extra costs for post-treatment care or extended stays in the destination country. This can reduce the overall cost-effectiveness of medical tourism for some patients. For instance, a medical tourism package for cosmetic surgery in Mexico may cost between $3,000 to $5,000 for the surgery, but the total cost (including flights, accommodation, and post-operative care) can easily reach $6,000 to $8,000, making it less affordable than anticipated.

Segment Analysis

The global medical tourism market is segmented based on type, treatment and region.

Treatment:

The medical treatment segment is expected to dominate the medical tourism market share

The medical treatment segment is the dominant segment in the medical tourism market, contributing significantly to its growth. This segment includes a wide range of medical services such as surgeries, dental procedures, fertility treatments and cosmetic surgery, all of which are key drivers of medical tourism.

For instance, according to the Global Healthcare Accreditation, the data (pre-pandemic levels), the below countries have statistics and data available for medical tourism. Some countries showcase inbound and other outbound data with the average number of patients and primary types of medical procedures sought as follows:

Surgical treatments, both elective and non-elective, make up a substantial part of the medical tourism market. High-demand surgeries like orthopedic surgeries, cardiac surgeries, cosmetic surgeries and spinal surgeries drive many patients to seek affordable and high-quality care abroad. Cosmetic surgery is one of the fastest-growing sectors within medical tourism. Procedures such as breast augmentation, liposuction, facelifts, bariatric surgery and dental implants draw a large number of international patients seeking quality and affordability abroad.

Geographical Analysis

Asia-Pacific is expected to hold a significant position in the medical tourism market share

The Asia-Pacific region is undeniably the dominant region in the medical tourism market, attracting millions of international patients each year due to its high-quality healthcare services, cost-effectiveness and well-established medical infrastructure. The dominance of the APAC region in medical tourism is driven by several factors, including the affordability of treatments, the availability of world-class healthcare facilities and the expertise of medical professionals.

For instance, India is experiencing a surge in medical tourism, with a significant increase in medical tourists from Myanmar, Bangladesh and Nepal. Despite being impacted by the coronavirus pandemic, India is becoming a popular destination for 'medical value travel', and its potential in this sector is expected to grow further. In 2024, India is expected to cater to around 7.3 million medical tourists, up from an estimated 6.1 million in 2023, according to credit rating agency Crisil.

Additionally, Thailand has become a world-renowned leader in medical tourism, attracting visitors worldwide with strong support from Thailand's Medical Tourism Association and the Thai government. According to the MedPark Hospital, in 2023, Thailand's medical tourism industry is expected to be worth $6 billion, with an estimated 3 million medical tourists receiving exceptional medical treatment and rehabilitation programs for a variety of medical fields.

The APAC region is home to many internationally accredited hospitals and healthcare facilities that provide high standards of medical care. Countries like Singapore, India, Thailand and South Korea have developed reputations for excellent healthcare infrastructure, attracting patients from across the globe. For instance, India is home to top-tier hospitals like Apollo Hospitals, Fortis Healthcare and Max Healthcare, which provide high-quality care for a wide range of medical procedures. Many of these hospitals have been accredited by global standards such as JCI, ensuring international patients receive the best care.

Competitive Landscape

The major global players in the medical tourism market include Raffles Medical Group, Medobal, Bookimed, RealSelf, Inc., KPJ Healthcare Berhad, Japan Dream Tour Co., Ltd., JTB Corp., SilaMed e.K., Medibliss Tours Limited, American Medical Care and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical tourism market report delivers a detailed analysis with 54 key tables, more than 41 visually impactful figures and 156 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Treatment
• 2.5. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Awareness About the Low Cost of Medical Procedures
  • 3.1.2. Restraints
    • 3.1.2.1. Medical Traveling is a Time-Consuming Process and is Associated with Some Additional Costs
  • 3.1.3. Opportunity
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Regulatory and Reimbursement Landscape
  • 4.4.1. North America
  • 4.4.2. Europe
  • 4.4.3. Asia Pacific
  • 4.4.4. Latin America
  • 4.4.5. Middle East & Africa
• 4.5. Porter's Five Force Analysis
• 4.6. Supply Chain Analysis
• 4.7. Patent Analysis
• 4.8. SWOT Analysis
• 4.9. Unmet Needs and Gaps
• 4.10. Recommended Strategies for Market Entry and Expansion
• 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.12. Pricing Analysis and Price Dynamics
• 4.13. Key Opinion Leaders
• 4.14. Future of Medical Tourism

5. Medical Tourism Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. International Medical Tourism*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Domestic Medical Tourism

6. Medical Tourism Market, By Treatment

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 6.1.2. Market Attractiveness Index, By Treatment
• 6.2. Medical Treatment*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Dental Treatment
  • 6.2.4. Organ Transplantation
  • 6.2.5. Cardiac Surgery
  • 6.2.6. Orthopedic Surgery
  • 6.2.7. Cancer Surgery
  • 6.2.8. Fertility Treatment
  • 6.2.9. Cosmetic Surgery
  • 6.2.10. Others
• 6.3. Wellness and Rejuvenation
• 6.4. Cures Through Traditional Systems of Medicines

7. Medical Tourism Market, By Regional Market Analysis and Growth Opportunities

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 7.1.2. Market Attractiveness Index, By Region
• 7.2. North America
  • 7.2.1. Introduction
  • 7.2.2. Key Region-Specific Dynamics
  • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.2.5.1. U.S.
    • 7.2.5.2. Canada
    • 7.2.5.3. Mexico
• 7.3. Europe
  • 7.3.1. Introduction
  • 7.3.2. Key Region-Specific Dynamics
  • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.3.5.1. Germany
    • 7.3.5.2. U.K.
    • 7.3.5.3. France
    • 7.3.5.4. Spain
    • 7.3.5.5. Italy
    • 7.3.5.6. Rest of Europe
• 7.4. South America
  • 7.4.1. Introduction
  • 7.4.2. Key Region-Specific Dynamics
  • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.4.5.1. Brazil
    • 7.4.5.2. Argentina
    • 7.4.5.3. Rest of South America
• 7.5. Asia-Pacific
  • 7.5.1. Introduction
  • 7.5.2. Key Region-Specific Dynamics
  • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.5.5.1. China
    • 7.5.5.2. India
    • 7.5.5.3. Japan
    • 7.5.5.4. South Korea
    • 7.5.5.5. Rest of Asia-Pacific
• 7.6. Middle East and Africa
  • 7.6.1. Introduction
  • 7.6.2. Key Region-Specific Dynamics
  • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Raffles Medical Group*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio and Description
  • 9.1.3. Financial Overview
  • 9.1.4. Key Developments
  • 9.1.5. SWOT Analysis
• 9.2. Medobal
• 9.3. Bookimed
• 9.4. RealSelf, Inc.
• 9.5. KPJ Healthcare Berhad
• 9.6. Japan Dream Tour Co., Ltd.
• 9.7. JTB Corp.
• 9.8. SilaMed e.K.
• 9.9. Medibliss Tours Limited
• 9.10. American Medical Care

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us